FIACLE This..

November 12, 2024 INDIANAPOLIS — During the American Academy of Optometry’s 2024 Annual Meeting, CooperVision‘s Myopia Luminaries Forum coincided with the fifth anniversary of MiSight 1 day contact lenses earning FDA approval.* “Celebrating this five-year milestone with some of the brightest minds in the industry was a meaningful way to honor this journey,” said Justin Kwan, OD, FAAO, Head, Myopia Management, CooperVision.

November 12, 2024 INDIANAPOLIS — At the American Academy of Optometry Meeting, Visioneering Technologies Inc. (VTI) shared new findings from Year One of the ongoing PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens) clinical trial. The PROTECT study, a randomized, double-masked, controlled clinical trial, evaluates the safety and effectiveness of NaturalVue Multifocal lenses for managing myopia progression in children.

October 10, 2024 Researchers in the field of myopia management from across the globe gathered in Hainan Island, China, for the International Myopia Conference from September 24 to September 28. Over the course of the conference, Review of Myopia Management highlighted many of the most important abstracts and posters that were presented at the event.